SCHEMBL15769359

SCHEMBL15769359

CC(C)(C)OC(=O)N1CCc2oc3cc(-n4ccc(CCc5ccc(Cl)cn5)nc4=O)ccc3c2C1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 7/20 0.36
PDE10A Q9Y233 1/20 0.35
KDM1A O60341 1/20 0.35
ESR2 Q92731 1/20 0.35
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
MAPK8 P45983 2/20 0.33
MKNK1 Q9BUB5 2/20 0.33
GPR119 Q8TDV5 1/20 0.33
BRD4 O60885 1/20 0.33
CREBBP Q92793 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15769127 0.96 MCHR1 (0.37) MCHR1PDE10AKDM1AESR2LMNA
SCHEMBL15769095 0.90 MCHR1 (0.38) MCHR1PDE10AKDM1AESR2LMNA
SCHEMBL15769348 0.89 MCHR1 (0.36) MCHR1
SCHEMBL15769341 0.85 MCHR1 (0.51) MCHR1
SCHEMBL15769623 0.84 MCHR1 (0.37) MCHR1HPGDHSD17B10
SCHEMBL15769267 0.82 MCHR1 (0.39) MCHR1KDM1AESR2LMNATP53
SCHEMBL15769138 0.81 MCHR1 (0.51) MCHR1
SCHEMBL15769455 0.81 MCHR1 (0.44) MCHR1KDM1A
SCHEMBL15769439 0.80 MCHR1 (0.52) MCHR1
SCHEMBL15781381 0.80 MCHR1 (0.38) MCHR1MEN1USP2HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140163012-A1 PYRIDO-/AZEPINO-BENZOFURAN AND PYRIDO-/AZEPINO-BENZOTHIOPHENE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF ALBANY MOLECULAR RESEARCH, INC. (US) 2014-06-12 US disclosed
US-20140163012-A1 PYRIDO-/AZEPINO-BENZOFURAN AND PYRIDO-/AZEPINO-BENZOTHIOPHENE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF ALBANY MOLECULAR RESEARCH, INC. (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163012-A1 PYRIDO-/AZEPINO-BENZOFURAN AND PYRIDO-/AZEPINO-BENZOTHIOPHENE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF MCHR1, MCHR2, TAAR1 MCHR1 1/4885PDE10A 3927/4885KDM1A 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.